PHILADELPHIA — (December 10, 2024) — The Wistar Institute assistant professors Nan Zhang, Ph.D., and Noam Auslander Ph.D., have both received independent funding totaling $1.2 million over the next…
PHILADELPHIA — (December 3rd, 2024) — The Wistar Institute’s David B. Weiner, Ph.D. — Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distin…
PHILADELPHIA — (Nov. 27, 2024) — Governor Josh Shapiro’s Administration, through the Commonwealth of Pennsylvania Redevelopment Assistance Capital Program (RACP), has granted The Wistar Institute $…
PHILADELPHIA — (Nov. 26, 2024) — The Wistar Institute’s Alessandro Gardini, Ph.D., and lab have shed new light on how certain biological processes determine the development of neural cells. Their f…
PHILADELPHIA — (November 21, 2024) — The Wistar Institute’s Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center’s Molecular and Cellular Oncogenesis Program, and lab …
PHILADELPHIA — (November 19, 2024) — A collaboration between The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential i…
PHILADELPHIA — (NOV. 14, 2024) — The Wistar Institute’s Hubert J.P. Schoemaker Education and Training Center was the recipient of a $100,000 eXperience grant from NIIMBL to support an immersive wee…
PHILADELPHIA — (October 22, 2024) —President and CEO of The Wistar Institute Dario Altieri, M.D., has been appointed to the Board of Directors of the Chamber of Commerce for Greater Philadelphia. T…
PHILADELPHIA — (October 11, 2024) — In the latest issue of The Philadelphia Business Journal, The Wistar Institute’s Maureen Murphy, Ph.D. — Deputy Director of the Ellen and Ronald Caplan Cancer Ce…
PHILADELPHIA — (Oct. 8, 2024) — New research from The Wistar Institute’s Salvino lab — led by professor Joseph Salvino, Ph.D. — has identified a novel series of SARS-CoV-2 Mpro inhibitors that may …
